OpenAI Rejects Apple Trade Secret Theft Claims 
CIA-Linked Investor Helped Quantum Systems Expand in US 
The Realist’s Case: Lukas Kerrebijn of RD Dubai on the Narrative Dubai’s Agents Won’t Question 
SpaceX Mobile Network Could Cost Up to $130 Billion, Bernstein Says 
Nvidia Pauses AI Cloud Financing Deals Amid Antitrust Concerns 
Pinterest Stock Falls as CFO Julia Brau Donnelly Resigns 
Street Poller Media and The Boom of the Street Interview Ad Industry 
U.S. Probes Apex Logistics Over Nvidia AI Chip Shipments to China 
PayPal Shares Sink as $50 Billion Takeover Bid Collapses 
GM Plans C$1.1 Billion Canada Investment Amid U.S. Tariff Pressure 
Trump Secures Drug Pricing Deals With Nine Pharma Companies 
Nvidia Reportedly Eyes $13 Billion Hugging Face Acquisition 
Honda, Nissan Eye Shared Vehicle Software Platform by 2029 
Trump Says ExxonMobil Among Oil Majors Planning Venezuela Return 
Shein Hong Kong IPO to Raise $1.7 Billion at $26.5 Billion Valuation 
Aon Nears $17 Billion Deal to Buy USI Insurance From KKR 
Toyota Global Sales Fall as China Demand Slumps 
Add as a preferred source on Google
WINDSOR, Conn., March 26, 2018 -- Scapa Healthcare, a trusted strategic outsource partner of skin-friendly, turnkey solutions, today announced the acquisition of Dallas, TX-based BioMed Laboratories. BioMed is a leading business-to-business developer and manufacturer of topical skin care solutions for advanced wound care, ostomy and consumer wellness markets.
Serving similar customer bases, BioMed is Scapa Healthcare’s first adjacent platform. The acquisition broadens Scapa’s offerings beyond adhesive-based solutions to now include complementary skin care offerings such as tubed hydrogel, wound cleansers, moisturizers and more. BioMed’s portfolio of products includes gels, creams, lotions, liquids, powders and hot fill waxes.
The addition of BioMed strengthens Scapa Healthcare’s offerings to its customers in the advanced wound care and ostomy markets, and expands market accessibility within consumer wellness segments such as OTC, first aid and health and beauty.
“At Scapa Healthcare, we remain committed to being the trusted strategic outsource partner of choice for our customers,” said Joe Davin, President Scapa Healthcare. “The acquisition of BioMed is in line with our continued growth strategy. We continue to expand our capabilities and product offerings while maintaining the level of excellence our partners expect.”
BioMed’s quality system is certified to ISO 13485 standards, and complies with FDA cGMP, Health Canada and EU regulatory requirements.
For more information on the acquisition, please visit http://www.scapa.com/en/news/AcquisitionofBioMedLaboratoriesLLC.
Learn more about BioMed Laboratories
About Scapa Healthcare
Scapa Healthcare is a global trusted strategic outsource partner of skin-friendly turnkey solutions for advanced wound care, consumer wellness and medical device markets. Scapa Healthcare partners with market leaders to design, develop, manufacture and commercialize innovative skin contact solutions to meet end-user needs. Scapa Healthcare offers turn-key development services, including design and project management; coating; converting, perforation and assembly; printing and packaging; and sterilization services. For more information, visit: www.scapahealthcare.com
Media Contact Jordan Bouclin SVM Public Relations and Marketing Communications [email protected] (401) 490-9700 Scapa Healthcare Contact Scapa Healthcare Marketing Communications Manager [email protected] (860) 902-8157
